HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William Spreen Selected Research

Viremia

11/2010A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William Spreen Research Topics

Disease

7Infections
12/2021 - 03/2002
3HIV Infections (HIV Infection)
12/2021 - 11/2013
3Hypersensitivity (Allergy)
11/2010 - 03/2002
2Injection Site Reaction
12/2021 - 12/2014
1Viremia
11/2010
1Dent disease 1
11/2010
1Acquired Immunodeficiency Syndrome (AIDS)
11/2010

Drug/Important Bio-Agent (IBA)

6cabotegravirIBA
12/2021 - 01/2015
3abacavir (Ziagen)FDA Link
11/2010 - 03/2002
2Rilpivirine (TMC-278)IBA
12/2021 - 11/2013
2HLA-B Antigens (HLA-B)IBA
04/2008 - 03/2002
1RacivirIBA
12/2021
1Emtricitabine (Emtriva)FDA Link
12/2021
1Tenofovir (Viread)FDA Link
12/2021
1IntegrasesIBA
12/2021
1Integrase InhibitorsIBA
01/2019
1TabletsIBA
01/2019
1HIV IntegraseIBA
01/2015
1Reverse Transcriptase InhibitorsIBA
11/2013
1Indinavir (Crixivan)FDA Link
11/2010
1DNA (Deoxyribonucleic Acid)IBA
11/2010
1NucleosidesIBA
11/2010
1RNA (Ribonucleic Acid)IBA
11/2010
1HLA-B57 antigenIBA
03/2002

Therapy/Procedure

5Injections
12/2021 - 12/2014
1Therapeutics
12/2014